You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Histone Deacetylase Inhibitors (HDACi)

Showing 1 - 25 of 4,422
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sarcoma Trial in Guangzhou (chidamide and toripalimab)

Recruiting
  • Sarcoma
  • chidamide and toripalimab
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Univerisity
Sep 4, 2022

HIV Trial in Puerto Rico, United States (Tamoxifen, Vorinostat, Antiretroviral drugs)

Active, not recruiting
Has Results
  • HIV Infections
  • Birmingham, Alabama
  • +13 more
Jan 13, 2022

Cutaneous T-Cell Lymphoma, Mature T-cell Malignancies, Peripheral T-Cell Lymphoma Trial run by the NCI (Romidepsin,

Recruiting
  • Cutaneous T-Cell Lymphoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Hematological Malignancies, Multiple Myeloma, Hodgkin's Lymphoma Trial in Worldwide (Tinostamustine)

Recruiting
  • Hematological Malignancies
  • +3 more
  • Phoenix, Arizona
  • +19 more
Apr 12, 2022

Safety and Efficacy Trial in Suzhou (Chidamide)

Recruiting
  • Safety and Efficacy
  • Suzhou, Jiangsu, China
    First Affiliated Hospital,Soochow University
Nov 30, 2021

HIV Trial in Melbourne (Disulfiram, (National Drug Code) NDC 0378-4141-01, Vorinostat, NDC 00006-0568-40)

Terminated
  • HIV Infections
  • Disulfiram, (National Drug Code) NDC 0378-4141-01
  • Vorinostat, NDC 00006-0568-40
  • Melbourne, Victoria, Australia
    Department of Infectious Diseases, Alfred Hospital
Oct 27, 2021

Leukemia, Leukemia, Acute, Leukemia, Lymphoblastic Trial in Guangzhou (Chidamide, Dasatinib)

Recruiting
  • Leukemia
  • +3 more
  • Guangzhou, Guangdong, China
    Department of Hematology, Nanfang Hospital
Jun 28, 2022

Adult T-cell Leukemia/Lymphoma, Extranodal NK-/T-cell Lymphoma, Nasal Type, Enteropathy-Associated T-Cell Lymphoma Trial run by

Not yet recruiting
  • Adult T-cell Leukemia/Lymphoma
  • +4 more
  • CC-486 (5-azacitidine)
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

HIV-1-infection Trial in Rotterdam (Valproic Acid, Pyrimethamine)

Completed
  • HIV-1-infection
  • Rotterdam, Netherlands
    Erasmus MC
Apr 28, 2021

Multiple Myeloma Trial in Lille Cedex, Nantes, Tours (JNJ-2641585 / VELCADE / Dexamethasone)

Completed
  • Multiple Myeloma
  • JNJ-2641585 / VELCADE / Dexamethasone
  • Lille Cedex, France
  • +2 more
Jan 21, 2020

Non Small Cell Lung Cancer Trial in United States (HBI-8000 in combination with pembrolizumab)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • HBI-8000 in combination with pembrolizumab
  • Goodyear, Arizona
  • +6 more
Dec 5, 2022

Small-cell Lung Cancer, Soft Tissue Sarcoma, Triple-negative Breast Cancer Trial in Canada, United States (Tinostamustine

Recruiting
  • Small-cell Lung Cancer
  • +4 more
  • Tinostamustine (EDO-S101)
  • Los Angeles, California
  • +7 more
Dec 22, 2020

Thrombocytopenia Trial (Chidamide, HD-DXM)

Not yet recruiting
  • Thrombocytopenia
  • (no location specified)
Jun 6, 2022

Osteosarcoma Trial (Tucidinostat, Apatinib)

Not yet recruiting
  • Osteosarcoma
  • Tucidinostat, Apatinib
  • (no location specified)
Nov 5, 2023

Renal Cell Carcinoma Trial in United States (LBH589)

Completed
Has Results
  • Renal Cell Carcinoma
  • Fort Myers, Florida
  • +9 more
Oct 26, 2021

Chronic Lymphocytic Leukemia Trial in Perugia (ITF2357)

Terminated
  • Chronic Lymphocytic Leukemia
  • Perugia, Italy
    Department of Internal Medicine and Public Health, University of
Jan 18, 2022

Metastatic Colorectal Cancer Trial in Australia (Sodium Valproate, Panitumumab, Cetuximab)

Recruiting
  • Metastatic Colorectal Cancer
  • Sodium Valproate
  • +2 more
  • Saint Leonards, New South Wales, Australia
  • +8 more
Jan 22, 2023

Hepatocellular Carcinoma (HCC) Trial in Taiwan (Chidamide, Regorafenib)

Recruiting
  • Hepatocellular Carcinoma (HCC)
  • Kaohsiung, Taiwan
  • +4 more
Mar 14, 2023

Non Hodgkin's Lymphoma Trial in China (Chidamide, Fludarabine and cyclophosphamide, Anti-CD19 CAR-T cells)

Recruiting
  • Non Hodgkin's Lymphoma
  • Beijing, Beijing, China
  • +12 more
Jun 9, 2022

Histone Deacetylase (HDAC) Activity Trial in Corvallis (BSE , Garlic oil, BSE)

Terminated
Has Results
  • Histone Deacetylase (HDAC) Activity
  • BSE placebo
  • +3 more
  • Corvallis, Oregon
    Oregon State University
Apr 8, 2019

Metastatic Solid Tumors Trial in San Francisco (PZP115891, PCI-24781)

Recruiting
  • Metastatic Solid Tumors
  • PZP115891, PCI-24781
  • San Francisco, California
    University of California, San Francisco
Aug 23, 2021

Esophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma Trial in Guangzhou

Recruiting
  • Esophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma
  • Tucidinostat (chidamide) and PD-1 inhibitor （Toripalimab）
  • Guangzhou, Guangdong, China
    Cancer center of Sun Yat-sen University
Jul 20, 2022

Advanced Lymphoma, Advanced Malignant Solid Tumor, Advanced Pancreatic Carcinoma Trial in New Haven (BET Bromodomain Inhibitor

Recruiting
  • Advanced Lymphoma
  • +13 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +2 more
  • New Haven, Connecticut
    Yale University Cancer Center LAO
Jun 29, 2022

HIV Trial in Brighton, London (Combination Antiretroviral Therapy (cART), Raltegravir, Vorinostat)

Active, not recruiting
Has Results
  • HIV
  • Combination Antiretroviral Therapy (cART)
  • +4 more
  • Brighton, United Kingdom
  • +5 more
Aug 24, 2021

Heart Failure With Normal Ejection Fraction, Left Ventricular Hypertrophy, Aortic Valve Stenosis Trial in Boston

Recruiting
  • Heart Failure With Normal Ejection Fraction
  • +3 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Mar 1, 2022